BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 10527977)

  • 21. Bone Mineral Density During and After Lactation: A Comparison of African American and Caucasian Women.
    Augustine M; Boudreau R; Cauley JA; Majchel D; Nagaraj N; Roe LS; Sood P; Stewart AF; Horwitz MJ
    Calcif Tissue Int; 2023 Oct; 113(4):426-436. PubMed ID: 37640959
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bone density in women receiving Norplant implants for contraception.
    Intaraprasert S; Taneepanichskul S; Theppisai U; Chaturachinda K
    J Med Assoc Thai; 1997 Nov; 80(11):738-41. PubMed ID: 9385772
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Reduced endothelial cell migratory signal production by endometrial explants from women using Norplant contraception.
    Subakir SB; Hadisaputra W; Siregar B; Irawati D; Santoso DI; Cornain S; Affandi B
    Hum Reprod; 1995 Oct; 10(10):2579-83. PubMed ID: 8567774
    [TBL] [Abstract][Full Text] [Related]  

  • 24. New approaches seek greater safety, appeal.
    Blaney CL
    Netw Res Triangle Park N C; 1995 Jun; 15(4):26-9. PubMed ID: 12289831
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Bone turnover in lactating adolescent: evaluation at the end of pregnancy, during and after the weaning period].
    Cattani A; Zubarew T; Maddaleno M; Mosso L; López JM
    Rev Med Chil; 2000 Feb; 128(2):145-53. PubMed ID: 10962882
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ovulatory dysfunction during continuous administration of low-dose levonorgestrel by subdermal implants.
    Faundes A; Brache V; Tejada AS; Cochon L; Alvarez-Sanchez F
    Fertil Steril; 1991 Jul; 56(1):27-31. PubMed ID: 1906017
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Serum prolactin levels in lactating women using progestasert system.
    Badraoui MH; Askalani H; Mahrous I; Osman MI; Bayad MA; Ibrahim II; Abdalla MT
    Popul Sci; 1981; (2):115-20. PubMed ID: 12339477
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The use of levonorgestrel implants (Norplant) for contraception in adolescent mothers.
    Polaneczky M; Slap G; Forke C; Rappaport A; Sondheimer S
    N Engl J Med; 1994 Nov; 331(18):1201-6. PubMed ID: 7935659
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effect of transdermal oestradiol on bleeding pattern, hormonal profiles and sex steroid receptor distribution in the endometrium of Norplant users.
    Boonkasemsanti W; Reinprayoon D; Pruksananonda K; Niruttisard S; Triratanachat S; Leepipatpaiboon S; Wannakrairot P
    Hum Reprod; 1996 Oct; 11 Suppl 2():115-23. PubMed ID: 8982753
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Contraceptive efficacy and clinical performance of Nestorone implants in postpartum women.
    Massai MR; Díaz S; Quinteros E; Reyes MV; Herreros C; Zepeda A; Croxatto HB; Moo-Young AJ
    Contraception; 2001 Dec; 64(6):369-76. PubMed ID: 11834236
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bone mineral density changes during lactation: maternal, dietary, and biochemical correlates.
    Krebs NF; Reidinger CJ; Robertson AD; Brenner M
    Am J Clin Nutr; 1997 Jun; 65(6):1738-46. PubMed ID: 9174469
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bone mineral loss during lactation and recovery after weaning.
    Kalkwarf HJ; Specker BL
    Obstet Gynecol; 1995 Jul; 86(1):26-32. PubMed ID: 7784018
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Failure of estrogen-induced discharge of luteinizing hormone in lactating women.
    Baird DT; McNeilly AS; Sawers RS; Sharpe RM
    J Clin Endocrinol Metab; 1979 Oct; 49(4):500-6. PubMed ID: 479342
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Twelve-month contraceptive continuation and repeat pregnancy among young mothers choosing postdelivery contraceptive implants or postplacental intrauterine devices.
    Cohen R; Sheeder J; Arango N; Teal SB; Tocce K
    Contraception; 2016 Feb; 93(2):178-83. PubMed ID: 26475368
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Risks and benefits, advantages and disadvantages of levonorgestrel-releasing contraceptive implants.
    Sivin I
    Drug Saf; 2003; 26(5):303-35. PubMed ID: 12650633
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Endometrial lymphomyeloid cells in abnormal uterine bleeding due to levonorgestrel (Norplant).
    Clark DA; Wang S; Rogers P; Vince G; Affandi B
    Hum Reprod; 1996 Jul; 11(7):1438-44. PubMed ID: 8671483
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Elevated parathyroid hormone-related peptide associated with lactation and bone density loss.
    Sowers MF; Hollis BW; Shapiro B; Randolph J; Janney CA; Zhang D; Schork A; Crutchfield M; Stanczyk F; Russell-Aulet M
    JAMA; 1996 Aug; 276(7):549-54. PubMed ID: 8709404
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Changes in calcium homeostasis over the first year postpartum: effect of lactation and weaning.
    Specker BL; Tsang RC; Ho ML
    Obstet Gynecol; 1991 Jul; 78(1):56-62. PubMed ID: 2047069
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Levonorgestrel contraceptive implants in female patients 14 to 21 years old.
    Suman VJ; Van Winter JT; Evans MP; Simmons PS; Jacobsen SJ; Manolis AL
    Mayo Clin Proc; 1998 Jan; 73(1):10-6. PubMed ID: 9443673
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A 5-year experience with Norplant implants in Thai women.
    Manonai J; Suthutvoravut S; Intaraprasert S
    Int J Gynaecol Obstet; 2003 Jul; 82(1):83-4. PubMed ID: 12834950
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.